EverSource Wealth Advisors’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
Other funds holding LYEL
OP
EverSource Wealth Advisors's LYEL Position: Q3 2026 in Review
EverSource Wealth Advisors opened a new position in Lyell Immunopharma (LYEL) in Q3 2026: 167 shares worth $1.64K. The stake represents ﹤0.01% of the portfolio and ranks #3819 among its holdings. This is a return to the name: EverSource Wealth Advisors previously reported a position in LYEL as recently as Q2 2025.
EverSource Wealth Advisors first reported a position in LYEL in Q2 2023 and has held it in 4 quarters since. 105 funds tracked by Wall St. Rank hold LYEL as of Q3 2026.
- EverSource Wealth Advisors held 167 shares of Lyell Immunopharma worth $1.64K as of Q3 2026.
- Lyell Immunopharma was a new EverSource Wealth Advisors position in Q3 2026.
- Lyell Immunopharma made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q3 2026, its #3819 holding.
- EverSource Wealth Advisors first reported a position in Lyell Immunopharma in Q2 2023 and has held it in 4 quarters since.
- 105 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q3 2026.
Based on EverSource Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.